Who are Confluence Pharmaceuticals's investors?

Confluence Pharmaceuticals's investors include Elevate Ventures, IU Ventures.

How much funding has Confluence Pharmaceuticals raised?

Confluence Pharmaceuticals has disclosed $1.3M raised across 2 rounds.

Where is Confluence Pharmaceuticals headquartered?

Confluence Pharmaceuticals is headquartered in Carmel, US.

Confluence Pharmaceuticals

Carmel, US · 2 known investors

Confluence Pharma is a clinical-stage biopharmaceutical company developing sustained-release drug formulations to treat the core social and communication impairments of Fragile X Syndrome, Autism, and other neurodevelopmental, neuropsychiatric, and addiction-related disorders. Its treatments target pediatric and adult patients, addressing symptoms such as communication, social behavior, attention, anxiety, and hyperactivity.

Biotech Digital Health

Founders & leadership

Steven L. JohnsPresident, CEO and Manager of the Issuer

Board

Boyd W. Sturdevant, Jr.Manager of the Issuer

Investors · 2

Elevate VenturesIndianapolis · $20K – $2M

IU VenturesBloomington

Reported raises · per SEC filings

Form D private placements

$1.3M disclosed across 2 rounds · 2016–2018

▶$10KraisedOct 2018 · 1 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Phil LodatoDirector
Steven L. JohnsExecutive Officer, Director
Boyd W. Sturdevant, Jr.Director

Offering amount: $800K
Amount sold: $10K
Minimum investment: $10K
First sale: Sep 2018
Incorporated: Limited Liability Company, Indiana
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.3MraisedNov 2016 · 10 investors · Pharmaceuticals

Rule 506(c)

Officers, directors & promoters on the filing

Boyd W. Sturdevant, Jr.Director
Steven L. JohnsExecutive Officer, Director

Offering amount: $1.3M
Amount sold: $1.3M
Minimum investment: $25K
First sale: Apr 2016
Incorporated: Limited Liability Company, Indiana
Federal exemptions: 06c

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap

Confluence Technologies4 shared keywordsConfluence provides data aggregation, analytics, and reporting solutions for investment consultants to analyze funds and deliver performance and risk insights to their clients.

Aclaris Therapeutics3 shared keywordsAclaris develops investigational monoclonal antibodies and small-molecule inhibitors targeting immune pathways for the treatment of atopic, autoimmune, and respiratory diseases. The company's clinical and preclinical pipeline includes candidates in development for severe asthma, atopic dermatitis, and T-cell-mediated autoimmune conditions.

Atlassian3 shared keywordsAtlassian offers a teamwork platform combining project planning, knowledge management, and AI orchestration tools for teams and their AI agents. Its products help organizations plan, execute, and deliver work at scale.

Circumvent3 shared keywordsCircumvent develops precision medicines for neurodegenerative diseases, with current focus on Batten Disease and other rare neurological disorders. The company's research targets synaptic dysfunction and lysosomal pathways through investigation of the palmitoylome.

Collegium Pharmaceutical3 shared keywordsCollegium Pharmaceutical is a biopharmaceutical company developing a portfolio of medications to treat serious medical conditions. It serves patients living with serious medical conditions and the healthcare professionals caring for them.

Companies competing with Confluence Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Confluence Pharmaceuticals do?: Confluence Pharma is a clinical-stage biopharmaceutical company developing sustained-release drug formulations to treat the core social and communication impairments of Fragile X Syndrome, Autism, and other neurodevelopmental, neuropsychiatric, and addiction-related disorders. Its treatments target pediatric and adult patients, addressing symptoms such as communication, social behavior, attention, anxiety, and hyperactivity.
Who are Confluence Pharmaceuticals's investors?: Confluence Pharmaceuticals's investors include Elevate Ventures, IU Ventures.
How much funding has Confluence Pharmaceuticals raised?: Confluence Pharmaceuticals has disclosed $1.3M raised across 2 rounds.
Where is Confluence Pharmaceuticals headquartered?: Confluence Pharmaceuticals is headquartered in Carmel, US.